nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PTGIR—pulmonary artery—dilated cardiomyopathy	0.134	0.445	CbGeAlD
Treprostinil—CYP2C9—cardial valve—dilated cardiomyopathy	0.118	0.393	CbGeAlD
Treprostinil—PPARD—heart—dilated cardiomyopathy	0.0238	0.0792	CbGeAlD
Treprostinil—PPARD—Pyruvate metabolism and Citric Acid (TCA) cycle—SDHA—dilated cardiomyopathy	0.0233	0.0736	CbGpPWpGaD
Treprostinil—PTGIR—heart—dilated cardiomyopathy	0.0182	0.0608	CbGeAlD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.0172	0.0543	CbGpPWpGaD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—PSEN1—dilated cardiomyopathy	0.0148	0.0466	CbGpPWpGaD
Treprostinil—Nadolol—ADRB1—dilated cardiomyopathy	0.014	0.543	CrCbGaD
Treprostinil—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0138	0.0387	CcSEcCtD
Treprostinil—Nadolol—ADRB2—dilated cardiomyopathy	0.0118	0.457	CrCbGaD
Treprostinil—PTGIR—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.0108	0.0341	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.00998	0.0315	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00905	0.0286	CbGpPWpGaD
Treprostinil—PPARD—The citric acid (TCA) cycle and respiratory electron transport—SDHA—dilated cardiomyopathy	0.00905	0.0286	CbGpPWpGaD
Treprostinil—Gout—Furosemide—dilated cardiomyopathy	0.00876	0.0245	CcSEcCtD
Treprostinil—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00829	0.0232	CcSEcCtD
Treprostinil—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00751	0.021	CcSEcCtD
Treprostinil—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00686	0.0192	CcSEcCtD
Treprostinil—Viral infection—Lisinopril—dilated cardiomyopathy	0.00679	0.019	CcSEcCtD
Treprostinil—Gout—Lisinopril—dilated cardiomyopathy	0.00657	0.0184	CcSEcCtD
Treprostinil—CYP2C9—heart—dilated cardiomyopathy	0.00652	0.0217	CbGeAlD
Treprostinil—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00632	0.0177	CcSEcCtD
Treprostinil—Neck pain—Lisinopril—dilated cardiomyopathy	0.00621	0.0174	CcSEcCtD
Treprostinil—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00614	0.0172	CcSEcCtD
Treprostinil—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0061	0.0171	CcSEcCtD
Treprostinil—PPARD—Ectoderm Differentiation—DMD—dilated cardiomyopathy	0.00604	0.0191	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00599	0.0189	CbGpPWpGaD
Treprostinil—Wheezing—Lisinopril—dilated cardiomyopathy	0.00596	0.0167	CcSEcCtD
Treprostinil—Malaise—Spironolactone—dilated cardiomyopathy	0.00593	0.0166	CcSEcCtD
Treprostinil—Discomfort—Spironolactone—dilated cardiomyopathy	0.00553	0.0155	CcSEcCtD
Treprostinil—Dehydration—Furosemide—dilated cardiomyopathy	0.00552	0.0155	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00551	0.0174	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00542	0.0171	CbGpPWpGaD
Treprostinil—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0054	0.0151	CcSEcCtD
Treprostinil—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00525	0.0147	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.0047	0.0148	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.0045	0.0142	CbGpPWpGaD
Treprostinil—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00446	0.0125	CcSEcCtD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—RAC1—dilated cardiomyopathy	0.00445	0.014	CbGpPWpGaD
Treprostinil—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00442	0.0124	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—LMNA—dilated cardiomyopathy	0.00435	0.0137	CbGpPWpGaD
Treprostinil—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00424	0.0119	CcSEcCtD
Treprostinil—Dehydration—Lisinopril—dilated cardiomyopathy	0.00414	0.0116	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00399	0.0126	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.00391	0.0123	CbGpPWpGaD
Treprostinil—Influenza—Lisinopril—dilated cardiomyopathy	0.00385	0.0108	CcSEcCtD
Treprostinil—Pruritus—Spironolactone—dilated cardiomyopathy	0.00379	0.0106	CcSEcCtD
Treprostinil—PTGIR—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.00374	0.0118	CbGpPWpGaD
Treprostinil—Bronchitis—Lisinopril—dilated cardiomyopathy	0.0037	0.0104	CcSEcCtD
Treprostinil—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00367	0.0103	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0036	0.0114	CbGpPWpGaD
Treprostinil—Erythema—Furosemide—dilated cardiomyopathy	0.00358	0.01	CcSEcCtD
Treprostinil—Dizziness—Spironolactone—dilated cardiomyopathy	0.00355	0.00993	CcSEcCtD
Treprostinil—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00345	0.00967	CcSEcCtD
Treprostinil—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00344	0.00963	CcSEcCtD
Treprostinil—Depression—Lisinopril—dilated cardiomyopathy	0.00342	0.00959	CcSEcCtD
Treprostinil—Vomiting—Spironolactone—dilated cardiomyopathy	0.00341	0.00955	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00339	0.0107	CbGpPWpGaD
Treprostinil—Rash—Spironolactone—dilated cardiomyopathy	0.00338	0.00947	CcSEcCtD
Treprostinil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00338	0.00946	CcSEcCtD
Treprostinil—Headache—Spironolactone—dilated cardiomyopathy	0.00336	0.00941	CcSEcCtD
Treprostinil—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00334	0.00935	CcSEcCtD
Treprostinil—Anaemia—Furosemide—dilated cardiomyopathy	0.0033	0.00926	CcSEcCtD
Treprostinil—Haematuria—Lisinopril—dilated cardiomyopathy	0.00327	0.00917	CcSEcCtD
Treprostinil—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00324	0.00907	CcSEcCtD
Treprostinil—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00322	0.00902	CcSEcCtD
Treprostinil—Nausea—Spironolactone—dilated cardiomyopathy	0.00319	0.00892	CcSEcCtD
Treprostinil—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00314	0.00879	CcSEcCtD
Treprostinil—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00309	0.00865	CcSEcCtD
Treprostinil—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00306	0.00857	CcSEcCtD
Treprostinil—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00304	0.0085	CcSEcCtD
Treprostinil—PTGIR—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.00303	0.00957	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00297	0.00938	CbGpPWpGaD
Treprostinil—Shock—Furosemide—dilated cardiomyopathy	0.00287	0.00804	CcSEcCtD
Treprostinil—Flushing—Lisinopril—dilated cardiomyopathy	0.00286	0.00801	CcSEcCtD
Treprostinil—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00286	0.008	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—TTN—dilated cardiomyopathy	0.00279	0.00881	CbGpPWpGaD
Treprostinil—Anorexia—Furosemide—dilated cardiomyopathy	0.00278	0.00779	CcSEcCtD
Treprostinil—Hypotension—Furosemide—dilated cardiomyopathy	0.00273	0.00764	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00271	0.00855	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00271	0.00855	CbGpPWpGaD
Treprostinil—Erythema—Lisinopril—dilated cardiomyopathy	0.00268	0.00751	CcSEcCtD
Treprostinil—Tension—Lisinopril—dilated cardiomyopathy	0.00263	0.00737	CcSEcCtD
Treprostinil—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00262	0.00734	CcSEcCtD
Treprostinil—Nervousness—Lisinopril—dilated cardiomyopathy	0.00261	0.0073	CcSEcCtD
Treprostinil—Back pain—Lisinopril—dilated cardiomyopathy	0.0026	0.00727	CcSEcCtD
Treprostinil—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00258	0.00722	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—TTN—dilated cardiomyopathy	0.00257	0.00811	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—FAS—dilated cardiomyopathy	0.00254	0.00801	CbGpPWpGaD
Treprostinil—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00254	0.0071	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00252	0.00794	CbGpPWpGaD
Treprostinil—Fatigue—Furosemide—dilated cardiomyopathy	0.00252	0.00705	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00251	0.00793	CbGpPWpGaD
Treprostinil—Pain—Furosemide—dilated cardiomyopathy	0.0025	0.00699	CcSEcCtD
Treprostinil—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00249	0.00697	CcSEcCtD
Treprostinil—Anaemia—Lisinopril—dilated cardiomyopathy	0.00248	0.00694	CcSEcCtD
Treprostinil—Angioedema—Lisinopril—dilated cardiomyopathy	0.00245	0.00687	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—ACTN2—dilated cardiomyopathy	0.00242	0.00764	CbGpPWpGaD
Treprostinil—Malaise—Lisinopril—dilated cardiomyopathy	0.00242	0.00678	CcSEcCtD
Treprostinil—Syncope—Lisinopril—dilated cardiomyopathy	0.00241	0.00674	CcSEcCtD
Treprostinil—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0024	0.00673	CcSEcCtD
Treprostinil—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00239	0.00668	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—AGT—dilated cardiomyopathy	0.00238	0.0075	CbGpPWpGaD
Treprostinil—Palpitations—Lisinopril—dilated cardiomyopathy	0.00237	0.00664	CcSEcCtD
Treprostinil—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00236	0.0066	CcSEcCtD
Treprostinil—Cough—Lisinopril—dilated cardiomyopathy	0.00234	0.00656	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00234	0.00737	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00231	0.0073	CbGpPWpGaD
Treprostinil—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00231	0.00646	CcSEcCtD
Treprostinil—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00231	0.00646	CcSEcCtD
Treprostinil—Myalgia—Lisinopril—dilated cardiomyopathy	0.00228	0.0064	CcSEcCtD
Treprostinil—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00228	0.0064	CcSEcCtD
Treprostinil—Chest pain—Lisinopril—dilated cardiomyopathy	0.00228	0.0064	CcSEcCtD
Treprostinil—Anxiety—Lisinopril—dilated cardiomyopathy	0.00228	0.00637	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00226	0.00714	CbGpPWpGaD
Treprostinil—Discomfort—Lisinopril—dilated cardiomyopathy	0.00226	0.00632	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—ACTN2—dilated cardiomyopathy	0.00223	0.00703	CbGpPWpGaD
Treprostinil—Oedema—Lisinopril—dilated cardiomyopathy	0.00219	0.00613	CcSEcCtD
Treprostinil—Infection—Lisinopril—dilated cardiomyopathy	0.00218	0.00609	CcSEcCtD
Treprostinil—Shock—Lisinopril—dilated cardiomyopathy	0.00215	0.00603	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00215	0.00679	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00215	0.00679	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00215	0.00679	CbGpPWpGaD
Treprostinil—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00214	0.006	CcSEcCtD
Treprostinil—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00214	0.00598	CcSEcCtD
Treprostinil—Asthenia—Furosemide—dilated cardiomyopathy	0.00209	0.00586	CcSEcCtD
Treprostinil—Anorexia—Lisinopril—dilated cardiomyopathy	0.00209	0.00584	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00208	0.00657	CbGpPWpGaD
Treprostinil—Pruritus—Furosemide—dilated cardiomyopathy	0.00206	0.00578	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—VCL—dilated cardiomyopathy	0.00206	0.00649	CbGpPWpGaD
Treprostinil—Hypotension—Lisinopril—dilated cardiomyopathy	0.00205	0.00573	CcSEcCtD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00204	0.00642	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—EGFR—dilated cardiomyopathy	0.00202	0.00638	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.002	0.00632	CbGpPWpGaD
Treprostinil—Diarrhoea—Furosemide—dilated cardiomyopathy	0.002	0.00559	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00199	0.00559	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00198	0.00625	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00198	0.00625	CbGpPWpGaD
Treprostinil—Insomnia—Lisinopril—dilated cardiomyopathy	0.00198	0.00555	CcSEcCtD
Treprostinil—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00197	0.00551	CcSEcCtD
Treprostinil—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00195	0.00547	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00194	0.00612	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00193	0.0061	CbGpPWpGaD
Treprostinil—Dizziness—Furosemide—dilated cardiomyopathy	0.00193	0.0054	CcSEcCtD
Treprostinil—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00193	0.0054	CcSEcCtD
Treprostinil—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0019	0.00533	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—VCL—dilated cardiomyopathy	0.00189	0.00598	CbGpPWpGaD
Treprostinil—Fatigue—Lisinopril—dilated cardiomyopathy	0.00189	0.00529	CcSEcCtD
Treprostinil—Pain—Lisinopril—dilated cardiomyopathy	0.00187	0.00524	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.00187	0.00589	CbGpPWpGaD
Treprostinil—Vomiting—Furosemide—dilated cardiomyopathy	0.00186	0.0052	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00184	0.00581	CbGpPWpGaD
Treprostinil—Rash—Furosemide—dilated cardiomyopathy	0.00184	0.00515	CcSEcCtD
Treprostinil—Dermatitis—Furosemide—dilated cardiomyopathy	0.00184	0.00515	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00183	0.00579	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00183	0.00578	CbGpPWpGaD
Treprostinil—Headache—Furosemide—dilated cardiomyopathy	0.00183	0.00512	CcSEcCtD
Treprostinil—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0018	0.00505	CcSEcCtD
Treprostinil—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00179	0.00501	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00178	0.00563	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00178	0.00561	CbGpPWpGaD
Treprostinil—Nausea—Furosemide—dilated cardiomyopathy	0.00173	0.00485	CcSEcCtD
Treprostinil—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00173	0.00485	CcSEcCtD
Treprostinil—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00173	0.00485	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00171	0.00539	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00169	0.00532	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00166	0.00522	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00164	0.00517	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00164	0.00517	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00161	0.00508	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ANKRD1—dilated cardiomyopathy	0.00161	0.00506	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00157	0.00496	CbGpPWpGaD
Treprostinil—Asthenia—Lisinopril—dilated cardiomyopathy	0.00157	0.0044	CcSEcCtD
Treprostinil—Pruritus—Lisinopril—dilated cardiomyopathy	0.00155	0.00434	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00152	0.00481	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00152	0.00481	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00151	0.00476	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00151	0.00476	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TAZ—dilated cardiomyopathy	0.00151	0.00476	CbGpPWpGaD
Treprostinil—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.0015	0.0042	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00148	0.00466	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00147	0.00462	CbGpPWpGaD
Treprostinil—Dizziness—Lisinopril—dilated cardiomyopathy	0.00145	0.00405	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00145	0.00456	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NR3C2—dilated cardiomyopathy	0.00143	0.00451	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0014	0.00443	CbGpPWpGaD
Treprostinil—Vomiting—Lisinopril—dilated cardiomyopathy	0.00139	0.0039	CcSEcCtD
Treprostinil—Rash—Lisinopril—dilated cardiomyopathy	0.00138	0.00387	CcSEcCtD
Treprostinil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00138	0.00386	CcSEcCtD
Treprostinil—Headache—Lisinopril—dilated cardiomyopathy	0.00137	0.00384	CcSEcCtD
Treprostinil—PPARD—Metabolism—SDHA—dilated cardiomyopathy	0.00136	0.00431	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00136	0.00429	CbGpPWpGaD
Treprostinil—Nausea—Lisinopril—dilated cardiomyopathy	0.0013	0.00364	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00126	0.00398	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.0012	0.00377	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00117	0.0037	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00117	0.00368	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00116	0.00366	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.0011	0.00347	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—TNF—dilated cardiomyopathy	0.00108	0.0034	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00107	0.00338	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00107	0.00337	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ITGB1—dilated cardiomyopathy	0.00103	0.00326	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ITGB1—dilated cardiomyopathy	0.000951	0.003	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000927	0.00292	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000927	0.00292	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NPPA—dilated cardiomyopathy	0.000899	0.00283	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000887	0.0028	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—CD36—dilated cardiomyopathy	0.000881	0.00278	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000862	0.00272	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000853	0.00269	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000853	0.00269	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000842	0.00266	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000842	0.00266	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000834	0.00263	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000832	0.00263	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—RAC1—dilated cardiomyopathy	0.000831	0.00262	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000817	0.00258	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—CD36—dilated cardiomyopathy	0.000811	0.00256	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000811	0.00256	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000793	0.0025	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000782	0.00247	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000775	0.00244	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000775	0.00244	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000768	0.00242	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—RAC1—dilated cardiomyopathy	0.000764	0.00241	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000758	0.00239	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00073	0.0023	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000725	0.00229	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00072	0.00227	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000713	0.00225	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000697	0.0022	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000681	0.00215	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000676	0.00213	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000656	0.00207	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000647	0.00204	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000622	0.00196	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000614	0.00194	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000596	0.00188	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000565	0.00178	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00056	0.00177	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—RAF1—dilated cardiomyopathy	0.000551	0.00174	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000525	0.00166	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000515	0.00163	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—RAF1—dilated cardiomyopathy	0.000507	0.0016	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000501	0.00158	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000497	0.00157	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000497	0.00157	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000483	0.00152	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000477	0.0015	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000462	0.00146	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000462	0.00146	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000458	0.00144	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000458	0.00144	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000455	0.00144	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000448	0.00141	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000439	0.00138	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000425	0.00134	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000419	0.00132	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000412	0.0013	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000382	0.00121	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GPX1—dilated cardiomyopathy	0.000371	0.00117	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000363	0.00114	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CD36—dilated cardiomyopathy	0.000361	0.00114	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000352	0.00111	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000334	0.00105	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AGT—dilated cardiomyopathy	0.000325	0.00103	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000323	0.00102	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000316	0.000997	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000312	0.000983	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000303	0.000957	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000291	0.000918	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000287	0.000905	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000282	0.000888	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000274	0.000866	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGT—dilated cardiomyopathy	0.000269	0.000849	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000259	0.000818	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGT—dilated cardiomyopathy	0.000248	0.000781	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000217	0.000684	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000199	0.000629	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000187	0.000589	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000172	0.000542	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000167	0.000528	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000163	0.000514	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000147	0.000463	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000128	0.000404	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000118	0.000372	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	7.45e-05	0.000235	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	7.26e-05	0.000229	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	6.54e-05	0.000206	CbGpPWpGaD
